Developing a new method to sterilize drugs using carbon dioxide
NovaAPI: Terminal Sterilization of Drug Substances and Products
['FUNDING_SBIR_2'] · NOVASTERILIS, INC. · NIH-11013394
This study is testing a new way to sterilize medicines using a special gas and a strong cleaning agent to make sure they are safe and effective for patients, helping drug makers improve their processes.
Quick facts
| Phase | ['FUNDING_SBIR_2'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | NOVASTERILIS, INC. (nih funded) |
| Locations | 1 site (LANSING, UNITED STATES) |
| Trial ID | NIH-11013394 on ClinicalTrials.gov |
What this research studies
This research focuses on creating a novel sterilization platform that utilizes supercritical carbon dioxide and a powerful sterilant called NovaKill™ to effectively sterilize drug substances and products. The goal is to improve the terminal sterilization process, which is crucial for ensuring the safety and efficacy of pharmaceuticals. By addressing the limitations of current sterilization methods, this research aims to provide a more efficient and reliable solution for drug manufacturers, ultimately benefiting patients who rely on sterile medications.
Who could benefit from this research
Good fit: Ideal candidates for benefiting from this research include patients who require sterile medications, such as those receiving injectable biologics or other pharmaceuticals.
Not a fit: Patients who do not require sterile medications or those using non-sterile drug formulations may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to safer and more effective sterilization methods for pharmaceuticals, enhancing patient safety.
How similar studies have performed: Other research has shown success with innovative sterilization methods, indicating potential for this approach to also yield positive results.
Where this research is happening
LANSING, UNITED STATES
- NOVASTERILIS, INC. — LANSING, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: SARKAR, ANKITA — NOVASTERILIS, INC.
- Study coordinator: SARKAR, ANKITA
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.